Freedom251 › Market Research Software
DrugPatentWatch
What DrugPatentWatch is
DrugPatentWatch is a paid pharmaceutical intelligence platform available through a web interface and API. It organizes patent, regulatory, and exclusivity information to help users examine branded medicines, generic entry, and pharmaceutical exclusivity. Its coverage includes active and expired patents in 134 countries, regulatory protections, and exclusivities. Tracking includes patent expiration dates, FDA exclusivities, Paragraph IV challenges, ANDA filings, biosimilar competition, and patent litigation. The Deep Research Engine provides cited quick answers, detailed research, business intelligence, and forecasts. Professional includes data export, unlimited searches, custom email alerts, and the Deep Research Engine, while Starter offers basic searches with limited monthly searches and no export or alerts. API delivery is offered in SQL, REST, XML, JSON, CSV, and HTML/iframe formats, with custom solutions available by inquiry. Data is also available through the Snowflake Marketplace. Plans include a $499 one-week Professional trial, Starter at $1,000/month, Professional at $3,000/month, and custom Enterprise pricing.
Who it suits
It suits pharmaceutical and biotech companies, generic manufacturers, biosimilar developers, investors, law firms, consultants, researchers, and healthcare institutions needing patent and regulatory intelligence.
What it does well
- Coverage spans patents in 134 countries
- Tracks FDA exclusivities and litigation
- Deep Research Engine provides forecasts
- Professional includes data export
- API offers multiple delivery formats
What to know first
- No free plan or free trial
- Starter has limited monthly searches
- Starter has no export or email alerts
- Professional is single-user access
Plans
| Plan | Billed and limits | Price |
|---|---|---|
| Starter | USD 1,000/month · Basic searches only · Limited monthly searches · No data export · No email alerts | $1,000 a month |
| Professional | USD 24,000/year · Single user · Unlimited searches · Data export · Custom email alerts · Deep Research Engine | $24,000 a year |
| Professional | USD 3,000/month · Single user · Unlimited searches · Data export · Custom email alerts · Deep Research Engine | $3,000 a month |
| Professional trial | $499/one week · Professional plan · All access · One week | $499, paid once |
| Starter | USD 8,000/year · Basic searches only · Limited monthly searches · No data export · No email alerts | $8,000 a year |
| Enterprise | Custom Investment · Unlimited enterprise users · No usage logging · Dedicated account director · Executive training program | On request |
As drugpatentwatch.com lists them, read 8 Oct 2026. The maker's own page has the final word.
Verdict
DrugPatentWatch combines broad pharmaceutical patent coverage with research, alerts, exports, and API delivery. Its paid plans and Starter limits make the plan details important before subscribing.
Facts from DrugPatentWatch's own pages
- Alerts
- Custom email alerts are included in Professional, and the site says alerts are available to users with active subscriptions. · drugpatentwatch.com, 8 Oct 2026
- API
- The maker offers API data delivery in SQL, REST API, XML/JSON/CSV, and HTML/iframe formats, with custom solutions available by inquiry. · drugpatentwatch.com, 8 Oct 2026
- Audience
- The maker says the platform is used by pharmaceutical and biotech companies, generic manufacturers, biosimilar developers, investors, law firms, consultants, researchers, and healthcare institutions. · drugpatentwatch.com, 8 Oct 2026
- Coverage
- The pricing page lists active and expired patents in 134 countries, regulatory protections, and exclusivities. · drugpatentwatch.com, 8 Oct 2026
- Enterprise privacy
- The Enterprise tier lists “Privacy: No usage logging.” · drugpatentwatch.com, 8 Oct 2026
- Exports
- Professional includes data export, while Starter lists no data export; the homepage says downloaded datasets are structured and exports belong to the user. · drugpatentwatch.com, 8 Oct 2026
- Founded
- 2002 · drugpatentwatch.com, 28 Sept 2026
- Headquarters
- Washington, DC, United States · drugpatentwatch.com, 28 Sept 2026
- Notable limits
- Starter has basic searches only and limited monthly searches; the Professional plan is described as single-user access. · drugpatentwatch.com, 8 Oct 2026
- Patent intelligence
- The platform tracks drug patents and expiration dates, FDA exclusivities, Paragraph IV challenges, ANDA filings, biosimilar competition, and patent litigation. · drugpatentwatch.com, 8 Oct 2026
- Purpose
- DrugPatentWatch organizes pharmaceutical patent and regulatory information to help users understand branded drugs, generic entry, and pharmaceutical exclusivity. · drugpatentwatch.com, 8 Oct 2026
- Research tools
- The Deep Research Engine offers cited quick answers, in-depth research, business intelligence, and forecasts. · drugpatentwatch.com, 8 Oct 2026
- Security
- The privacy policy says the company uses reasonable security safeguards to protect personal information and was last updated July 25, 2017. · drugpatentwatch.com, 8 Oct 2026
- Snowflake
- A DrugPatentWatch maker blog post says its data is available on the Snowflake Marketplace for querying and joining with internal datasets. · drugpatentwatch.com, 8 Oct 2026
- Support
- The contact page lists thinkBiotech LLC at 1133 15th Street NW, 12th Floor, Washington, DC 20005, and provides a phone number and contact form. · drugpatentwatch.com, 8 Oct 2026
Where DrugPatentWatch stands on Freedom251
- Market Research Software#35 of 59